A recently developed protocol with a dual echo RF-spoiled gradient echo acquisition enabled simultaneous measurement of dynamic OE signal change and the substantial ∆R2* effect at 3 tesla. To progress towards clinical translation, we evaluated repeatability and reproducibility across two sites, vendors and time points. Our results demonstrate good repeatability for the quantitative and semi-quantitative indices across time points, consistent signal behaviour and repeatable ∆R2* across two sites and vendors, suggesting potential utility in multi-centre clinical studies. However, echo time dependence should be considered when interpreting percentage signal enhancement.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: